Relief Cardiovascular
PrivateLast Round
Series A
Jan 8, 2025
Total Funding Raised
$12M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Relief Cardiovascular is a medical device company that is developing the Relief System, a transcatheter smart implant designed to monitor and modulate venous pressure to manage congestion in heart failure patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Clinical Trials, Sensors
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Relief Cardiovascular Comparables
Compare Relief Cardiovascular with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adona Medical | 79% | |
| Johnson & Johnson | 73% | |
| Alleviant Medical | 73% |
Relief Cardiovascular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 8, 2025 |
Key People
Founding team and executive leadership
Relief Cardiovascular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Good Growth Capital | Series A |
| Advent Life Sciences | Series A |
| Broadview Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 36% MoM.
- Jul 21, 2026
Grew 29% QoQ, from 14 to 18 employees.
Relief Cardiovascular Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Relief Cardiovascular's valuation, stock price, and market status.
Is Relief Cardiovascular a public or private company?
Relief Cardiovascular is a private company.
What is the current stock price of Relief Cardiovascular?
Relief Cardiovascular is a private company with no public stock price. No recent secondary market data is available.
How much is Relief Cardiovascular worth (valuation)?
Valuation information for Relief Cardiovascular is not publicly available.
Can I buy Relief Cardiovascular stock?
Relief Cardiovascular shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Relief Cardiovascular's last funding round?
Relief Cardiovascular's most recent funding round was Series A on January 8, 2025.
Who are the main investors in Relief Cardiovascular?
Key investors in Relief Cardiovascular include Advent Life Sciences, Broadview Ventures.
Will Relief Cardiovascular IPO soon?
No public IPO plans have been announced for Relief Cardiovascular.
How can I track Relief Cardiovascular secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Relief Cardiovascular's secondary market activity and sign up for updates.